
The OxyLo Team
Our Story
OxyLo is a San Diego based Biotechnology company. We focus on helping liver patients get their life back. Our patent pending HypoxyCaps are a revolutionary biomaterial-based implant designed to actively remove oxygen and glucose from the inside of a tumor. Our mission is to starve these tumors to give hope and time back to patients who need it most.
We are a team of international PhD scientists with a combined 40 years of experience working in biology, chemistry, and engineering. Our philosophy of focusing on creativity and interdisciplinary science has led to the breakthrough innovations that we aim to provide today.
Core management team
Scientific Advisory Board
Isabel Newton, M.D., Ph.D. Interventional Radiologist
Tom Molley, PhD Chief Executive Officer
& Co-founder
Rebekah white, MD, FACS Surgical Oncologist
Kristopher Kilian, PhD Chief Scientific Advisor
& Co-founder
James Mackay, PhD
CEO of Kateran Consulting
Erin LaMontagne, PhD VP of Research & Development
Mike Damore, PhD
CEO of Damore TransMed Consulting
Mike Hoerres, MS
CEO at Aquinas Life Sciences
